References
- Collins-Gold LC, Lyons RT, Bartholow LC. Parenteral emulsions for drug delivery. Adv Drug Deliv Rev 1990; 5: 189–208
- Franklin WA, Waintrub M, Edwards D, Christensen K, Prendegrast P, Woods J, Bunn PA, Kolhouse JF. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int J Cancer 1994, Suppl 8: 89–95
- Hande KR. Etoposide pharmacology. Semin Oncol 1992; 19(suppl 13)3–9
- Leamon CP, Low PS. Selective targeting of malignant cells with cytotoxin-folate conjugates. J Drug Target 1994; 2: 101–112
- Lee RJ, Low PS. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophysic Acta 1995; 1233: 134–144
- Maruyama K, Takizawa T, Takahashi N. Targeting efficiency of PEG-immunoliposome-conjugated antibodies at PEG terminals. Adv Drug Deliv Rev 1997; 24: 235–242
- Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA. Tumor selective radiopharmaceutical targeting via receptor-mediated endocytosis of Gallium-67-deferoxamine-foalte. J Nucl Med 1996; 37: 1003
- Morshed KM, Ross DM, McMartin KE. Folate transport proteins mediate the bi-directional transport of 5-methyltetrahydrofolate in cultured human proximal tubule cells. J Nutr 1997; 127: 1137
- Overath P, Engstler M. Endocytosis, membrane recycling and sorting of GPI-anchored proteins: Trypanosoma brucei as a model system. Mol Microbiol 2004; 53: 735–744
- Patlolla RR, Venkateswarlu V. Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J Pharm Sci 2005; 94: 437–445
- Pelkmans L, Helenius A. Endocytosis via caveolae. Traffic 2002; 3: 311–320
- Reddy PR, Venkateswarlu V. Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion. J Drug Targ 2005; 13: 543–553
- Reddy JA, Dean D, Kennedy MD, Low PS. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J Pharm Sci 1999a; 88: 1112–1118
- Reddy JA, Haneline LS, Srour EF, Antony AC, Clapp W, Low PS. Expression and functional characterization of the β-isoform of the folate receptor on CD34+ cells. Blood 1999b; 93: 3940–3948
- Seki J, Sonoke S, Saheki A, Fukui H, Sasaki H, Mayumi T. A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting. Int J Pharm 2004; 273: 75–83
- Sengupta S, Tyagi P, Velpandian T, Gupta YK, Gupta SK. Etoposide encapsulated in positively charged liposomes: Pharmacokinetic studies in mice and formulation stability studies. Pharmacol Res 2000; 42: 459–464
- Sengupta S, Tyagi P, Chandra S, Kochupillai V, Gupta SK. Encapsulation in cationic liposomes enhances antitumor efficiency and reduces the toxicity of etoposide, a topoisomerase-II inhibitor. Pharmacology 2001; 62: 63–171
- Shinoda T, Takagi A, Maeda A, Kagatani S, Konno Y, Hashida M. In vivo fate of folate-BSA in non-tumor- and tumor-bearing mice. J Pharm Sci 1998; 87: 1521–1526
- Venkateswarlu V, Patlolla RR. Lipid microspheres as drug delivery systems. Ind J Pharm Sci 2001; 63: 450–458